- Home
- PXLW vs INMB Comparison
PXLW vs INMB Comparison
Compare PXLW & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PXLW | INMB |
|---|---|---|
| Founded | 1997 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.7M | 44.1M |
| IPO Year | 2000 | 2019 |
Fundamental Metrics
Financial Performance| Metric | PXLW | INMB |
|---|---|---|
| Price | $7.06 | $1.56 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 3 |
| Target Price | ★ $14.33 | $4.30 |
| AVG Volume (30 Days) | 102.2K | ★ 472.5K |
| Earning Date | 02-11-2026 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $33,205,000.00 | $50,000.00 |
| Revenue This Year | N/A | $264.29 |
| Revenue Next Year | $3.54 | $14,337.26 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 19.05 |
| 52 Week Low | $4.67 | $1.38 |
| 52 Week High | $15.42 | $11.64 |
Technical Indicators
Market Signals| Indicator | PXLW | INMB |
|---|---|---|
| Relative Strength Index (RSI) | 55.84 | 39.84 |
| Support Level | $6.13 | $1.75 |
| Resistance Level | $6.84 | $1.63 |
| Average True Range (ATR) | 0.41 | 0.11 |
| MACD | 0.08 | -0.04 |
| Stochastic Oscillator | 85.04 | 17.71 |
Price Performance
Historical ComparisonAbout PXLW Pixelworks Inc.
Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in Japan.
About INMB INmune Bio Inc.
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.